AmerisourceBergen, TrakCel debut platform to speed access to cell therapies

FierceBiotech, Ravi Nalliah

AmerisourceBergen and partner TrakCel rolled out a new platform designed to speed access to prescribed cell and gene therapies to patients. The platform is designed to provide visibility throughout a patient’s cell and gene therapy by combining TrakCel’s advanced therapy orchestration platform, Ocellos, and AmerisourceBergen’s Fusion system, which is a customer relationship management and support platform offered by the company’s Lash Group.

For the full article, please visit FierceBiotech